Implante Percutâneo Transeptal de Bioprótese em Disfunção de Prótese Valvar Cirúrgica Mitral - Experiência Multicêntrica Brasileira / Percutaneous Transseptal Bioprosthetic Implantation in Failed Prosthetic Surgical Mitral Valve - Brazilian Multicenter Experience

Resumo Fundamento A intervenção percutânea em pacientes com disfunção de prótese biológica mitral apresenta-se como uma alternativa ao tratamento cirúrgico convencional. Objetivo Relatar a primeira experiência brasileira de implante transcateter de bioprótese valve-in-valve mitral via transeptal (TMVIV-via transeptal). Métodos Foram incluídos pacientes portadores de disfunção de bioprótese cirúrgica submetidos ao TMVIV-transeptal em 12 hospitais brasileiros. Foram considerados estatisticamente significativos valores de p<0,05. Resultados Entre junho/2016 e fevereiro/2019, 17 pacientes foram submetidos ao TMVIV-via transeptal. A mediana de idade foi 77 anos (IIQ,70-82), a mediana do escore STS-PROM foi 8,7% (IIQ,7,2-17,8). Todos os pacientes tinham sintomas limitantes de insuficiência cardíaca (CF≥III), tendo 5 (29,4%) sido submetidos a mais de uma toracotomia prévia. Obteve-se sucesso do TMVIV-via transeptal em todos os pacientes. A avaliação ecocardiográfica demonstrou redução significativa do gradiente médio (pré-intervenção, 12±3,8 mmHg; pós-intervenção, 5,3±2,6 mmHg; p<0,001), assim como aumento da área valvar mitral (pré-intervenção, 1,06±0,59 cm2; pós-intervenção, 2,18±0,36 cm2; p<0,001) sustentados em 30 dias. Houve redução significativa e imediata da pressão sistólica de artéria pulmonar, com redução adicional em 30 dias (pré-intervenção, 68,9±16,4 mmHg; pós-intervenção, 57,7±16,5 mmHg; 30 dias, 50,9±18,7 mmHg; p<0,001). Durante o seguimento, com mediana de 162 dias (IIQ, 102-411), observou-se marcada melhora clínica (CF≤II) em 87,5%. Um paciente (5,9%) apresentou obstrução de via de saída de ventrículo esquerdo (VSVE), evoluindo para óbito logo após o procedimento, e outro morreu aos 161 dias de seguimento.Conclusão: A primeira experiência brasileira de TMVIV-transeptal demonstra a segurança e a efetividade dessa nova técnica. A obstrução da VSVE é uma complicação potencialmente fatal, reforçando a importância da seleção dos pacientes e do planejamento do procedimento. (Arq Bras Cardiol. 2020; [online].ahead print, PP.0-0)

Abstract Background Percutaneous intervention in patients with bioprosthetic mitral valve dysfunction is an alternative to conventional surgical treatment. Objectives To report the first Brazilian experience with transseptal transcatheter bioprosthetic mitral valve-in-valve implantation (transseptal-TMVIV). Methods Patients with surgical bioprosthetic dysfunction submitted to transseptal-TMVIV in 12 Brazilian hospitals were included. The significance level adopted was p<0.05. Results From June/2016 to February/2019, 17 patients underwent transseptal-TMVIV. Their median age was 77 years (IQR,70-82) and median Society of Thoracic Surgeons predicted risk of mortality (STS-PROM) score was 8.7% (IQR,7.2-17.8). All patients had limiting symptoms of heart failure (FC≥III) and 5 (29.4%) had undergone more than one previous thoracotomy. Transseptal-TMVIV was successful in all patients. Echocardiographic assessment showed a significant reduction in mean mitral valve gradient (pre-intervention, 12±3.8 mmHg; post-intervention, 5.3±2.6 mmHg; p<0.001), in addition to an increase in mitral valve area (pre-intervention, 1.06±0.59 cm2; post-intervention, 2.18±0.36 cm2; p<0.001) sustained for 30 days. There was a significant and immediate reduction in the pulmonary artery systolic pressure, with an additional reduction in 30 days (pre-intervention, 68.9±16.4 mmHg; post-intervention, 57.7±16.5 mmHg; 30 days, 50.9±18.7 mmHg; p<0.001). During follow-up (median, 162 days; IQR, 102-411), significant clinical improvement (FC≤II) was observed in 87.5% of the patients. One patient (5.9%) had left ventricular outflow tract (LVOT) obstruction and died right after the procedure, and another died at 161 days of follow-up. Conclusion The first Brazilian experience with transseptal-TMVIV shows the safety and effectivity of the new technique. The LVOT obstruction is a potentially fatal complication, reinforcing the importance of patients' selection and of procedural planning. (Arq Bras Cardiol. 2020; [online].ahead print, PP.0-0)

Evolução pós-operatória da função ventricular esquerda na insuficiência aórtica / Postoperative Left Ventricular Function Evolution in Aortic Insufficiency

PURPOSE--To analyze the follow-up of left ventricular function (LVF) after surgical correction of severe chronic aortic insufficiency (AI). METHODS--Twenty-one out of 68 patients with AI, initially asymptomatic and that developed symptoms during the follow-up period of 24-36 months, were studied. Relationship between symptoms and LVF by echocardiogram and radioisotopic ventriculography at rest and in isotonic exercise were studied. Three clinical moments (CM) were assumed: CM-0- at the beginning of the study, when all patients were asymptomatic; CM-1- manifestation of the symptoms during 24-36 months; CM-2- corresponding to the late post-operative period of 8 months of 20 out of 21 patients (one refused the surgery). The analysis did not show any significant differences between the mean values of all echocardiographic variables (diastolic and systolic diameters, shortening fraction, final systolic stress, volume-mass ratio, contractility index) and the ejection fraction of the left ventricle (EF) obtained by the radioisotope ventriculography at rest and, including exercise, between clinical moments 0 and 1. RESULTS--In the CM-2, involution was verified for functional class I/II in all cases and absence of expressive complications or immediate or late postoperative mortality. Comparison between CM-2 and 0 showed expressive regression of the diameters at rest in the postoperative period and with significant improvement in the means mainly the percentual variation of the EF and total time of effort. CONCLUSION--Symptoms assembled patients with more advanced eccentric hypertrophy and did not coincide with any immediate change in findings studied at rest and at exercise. It represented a point of reference for surgical indication compatible with late postoperative involution of chronic adaptation of AI.

Objetivo - Analisar a evolução da função ventricular esquerda (FVE) após correção cirúrgica da insuficiência aórtica crônica grave (IAo). Métodos - Dentre 68 portadores de IAo, inicialmente assintomáticos, selecionamos 21 que desenvolveram sintomas durante período de observação de 24-36 meses. Estudamos a FVE através do ecodopplercardiograma e da ventriculografia radioisotópica em repouso e em exercício isotônico em três momentos clínicos (MC): MC-0 - ao início do estudo e todos os pacientes eram assintomáticos; MC-1 - manifestação de sintomas no decorrer de 24-36 meses; MC-2 - período pós-operatório tardio de 8 meses de 20 dos 21 casos (houve uma recusa à cirurgia). Não havia diferenças significantes entre as médias de todas as variáveis ecocardiográficas estudadas (diâmetro diastólico, diâmetro sistólico, fração de encurtamento, estresse sistólico final, relação volume-massa, índice de contratilidade) e da fração de ejeção do ventrículo esquerdo (FE) obtida pela ventriculografia radioisotópica em repouso e, inclusive ao exercicio, entre os MC - 0 e 1. Resultados - No MC-2 constatou -se involução para classe funcional I/II em todos os casos e ausência de mortalidade pós-operatória imediata e tardia. Da comparação entre os MC - 2 e 0, houve expressiva regressão dos diâmetros em repouso no pós-operatório e com melhora significante entre as médias, principalmente da variação percentual da FE e do tempo total de esforço. Conclusão - A manifestação de sintomas reuniu pacientes com hipertrofia excêntrica avançada, não coincidiu com nenhuma mudança imediata dos marcadores laboratoriais estudados ao repouso e ao exercício, e representou ponto de referência de indicação cirúrgica compatível com involução pós-operatória tardia das conseqüências da adaptação IAo

Defeito do septo interventricular adquirido no curso de endocardite infecciosa / Acquired ventricular septal defect during infective endocarditis

We studied five patients with acquired ventricular septal defect during the course of an infective endocarditis. All patients were male and had a previous aortic valve disease associated with an aortic ring abscess. Clinical examination was useful for the diagnosis of 4 cases, emphasizing the following findings: systolic murmur and/or left paraesternal thrill and right-heart failure. Incidence of congestive heart failure was 60//, while 40//of all patients died during the in-hospital course. No specific etiologic agent was detected. Therefore, acquired ventricular septal defect should be suspected in patients with infective endocarditis of the aortic valve that evolve with a systolic murmur and/or paraesternal thrill and right-heart failure. Immediate surgical treatment is mandatory in these cases

Prevencao de recorrencia de fibrilacao atrial apos cardioversao / Prevention of atrial fibrilation recurrence after cardioversion

A fibrilacao atrial e arritmia frequent com alto indice de recorrencia apos reversao para ritmo sinusal. O uso de drogas antiarritmicas para a manutencao do ritmo sinusal e considerado benefico se comparado com placebo. Essas drogas geralmente sao as mesmas empregadas na reversao, incluindo, entre as disponiveis em nosso meio, quinidina, amiodarona, disopiramida e sotalol. Digital, outros betabloqueadores e bloqueadores de canal de calcio parecem mais efetivos para diminuicao da resposta ventricular. O beneficio do digital e indubitavel na reversao e provavelmente na namutencao do ritmo sinusal . Usamos com frequencia quinidina, associada ou nao a digital, como primeira opcao, principalmente quando foram eficazes na reversao. Amiodarona parece mais efetiva na prevencao de recorrencia de fibrilacao atrial; entretanto seus efeitos colaterais a longo prazo sao mais frequentes e mais graves. Nos portadores de disfuncao ventricular importante, ou naqueles que durante os paroxismos de fibrilacao atrial apresentam instabilidade hemodinamica ou fenomenos embolicos, nos quais a manutencao do ritmo sinusal e altamente desejavel e necessaria, a amiodarona e a droga de primeira escolha. Algumas doencas cardiacas ou extracardiacas e alguns fatores desencadeantes de recorrencias devem ser analisados e tratados antes ou concomitantemente ao uso de antiarritmicos. A conveniencia da manutencoa do ritmo sinusal e consideracoa que deve ser feita nos casos que apresentam alto indice de paroxismos ou nos propensos a efeitos pro-arritmicos, nos quais o custo/beneficio e alto.

Eventos neurológicos na endocardite infecciosa / Neurologicol Events in Infective Endocorditis

PURPOSE--The study of frequency, modalities and course of neurological complications of infective endocarditis (IE), as well as the current indication and value of supplementary examinations. METHODS--Sixty-three patients with IE, 39 with native valve and 24 with valvar prosthesis, were prospectively studied; the mean age was 42 years and 45 (71.4 per cent ) were males. Two groups were formed: A) 41 patients without neurological events and B) 22 patients who presented 28 neurological events before or during hospitalization: ischemic cerebrovascular accident 20, hemorrhagic cerebrovascular accident 2, meningeal hemorrhage 2, meningitis 2, brain abscess 1 and seizure 1. All patients were submitted to neurological clinical examination; 57 computerized tomographies of the cranium, 28 arteriographies and 32 cerebrospinal fluid analysis were performed. RESULTS--The incidence of neurological events corresponded to 34.92 per cent of IE patients, with a clear predominance (85.71 per cent ) of vascular as compared to infectious manifestations. Mortality was 2.32 times higher in group B patients (22.73 per cent x 9.76 per cent ), albeit p = 0.256, and was not related to staphylococcal etiology. The neurological events were not related to sex, age and presence of valvar prosthesis. The presence of neurological complications was greater (p = 0.047) in patients with simultaneous infections in two valves (mitral and aortic) and also (p = 0.00884) in those with IE in prosthesis implanted for less than three months. All supplementary neurological examinations in group A were normal. CONCLUSION--1) Occurrence of neurological events is a factor which influences the prognosis of IE; 2) supplementary neurological examinations did not reveal subclinical neurological complications; 3) neurological complications were significantly more frequent in patients with simultaneous mitral and aortic valve IE; 4) IE in prosthesis implanted for less than 3 months has a greater probability to develop a neurological picture as compared to IE in prosthesis implanted for more than 3 months

Purpose - The study of frequency, modalities and course of neurological complications of infective endocartitis (IE), as well as the current indication and value of suplementary examinations. Methods - Sixty-three patients with IE, 39 with native valve and 24 with valvar prosthesis, were prospectively studied; the mean age was 42 years and 45 (71,4%) were males. Two groups were formed: A) 41 patients without neurological events and B) 22 patients who presented 28 neurological events before or during hospitalization: ischemic cerebrovascular accident 20, hemorrhagic cerebrovascular accident 2, meningeal hemorrhage 2, meningitis 2, brain abscess 1 and seizure 1. All patients were submitted to neurological clinical examination; 57 computerized tomographies of the cranium, 28 arteriographies and 32 cerebrospinal fluid analysis were performed. Results - The incidence of neurological events corresponded to 34.92% of IE patients, with a clear predominance (85.71%) of vascular as compared to infectious manifestations. Mortality was 2.32 times higher in group B patients (22.73% x 9.76%), albeit p=0.256, and was not related to staphilococcal etiology. The neurological events were not related to sex, age and presence of valvar prosthesis. The presence of neurological complications was greater (p=0.047) in patients with simultaneous infections in two valves (mitral and aortic) and also (p=0.00884) in those with IE in prosthesis implanted for less than three months. All supplementary neurological examinations in group A were normal. Conclusion - 1) Occurrence of neurological events is a factor which influences the prognosis of IE; 2) supplementary neurological examinations did not reveal subclinical neurological complications; 3) neurological complications were signifcantly more frequent in patients with simultaneous mitral and aortic valve IE; 4) IE in prosthesis implanted for less than 3 months has a greater probability to develop a neurological picture as compared to IE in prosthesis implanted for more than 3 months

Pneumonite e fibrose pulmonar por amiodarona: relato de dois casos com microscopia óptica e eletrônica / Pneumonitis and pulmonary fibrosis due to amiodarone: report of 2 cases with optic and electronic microscopy

Relatam-se dois casos de pacientes medicados com amiodarona para controle de extrasístoles ventriculares que desenvolveram dispnéia, tosse seca, posteriormente produtiva, hipoxemia acentuada, aumento da velocidade de hemossedimentaçäo e dos níveis séricos da mucoproteína. O 1.- paciente, que também apresentou inapetência, emagrecimento e febrícula, fez inicialmente uso de 400 mg/dia durante 14 meses e de 200 mg/dia (5 dias/semana) nos últimos 5 meses. O 2.- paciente recebeu 200 mg/dia durante 5 anos. Ambos exibiam níveis séricos da amiodarona e de seu metabólito, N-desetil amiodarona, em níveis aceitos como terapêuticos. A radiogragia de tórax revelou infiltrado intersticial, difuso, bilateral e a cintilografia pulmonar com citrato de gálio 67, realizada em um dos pacientes, evidenciou hipercaptaçäo difusa. A biopsia de pulmäo nos dois pacientes foi compatível com pneumonite e fibrose pulmonar, observando-se, pela microscopia eletrônica, inclusöes citoplasmáticas lamelares. Os corpos de inclusäo foram também detectados em neutrófilos do sangue periférico nos dois pacientes e no fígado do 2.- paciente, que foi submetido a necropsia. Os pacientes apresentaram rapidamente insuficiência respiratória severa apesar da suspensäo do medicamento e o tratamento com corticosteróide foi ineficaz. Ambos os pacientes faleceram